| 1 |
Neofytos D, Chatzis O, Nasioudis D, et al. Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study[J]. Transpl Infect Dis, 2018，20(4)：e12898.
|
| 2 |
Husain S, Camargo JF. Invasive aspergillosis in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019，33(9)：e13544..
|
| 3 |
Amin A, Molina A, Quach L, et al. Liver transplantation in patients with pretransplant aspergillus colonization: is it safe to proceed？[J]. Transplantation, 2021，103(3): 586-592.
|
| 4 |
Fortún J, Muriel A, Martín-Dávila P, et al. Caspofungin versus fluconazole as prophylaxis of invasive fungal infection in high-risk liver transplantation recipients: a propensity score analysis[J]. Liver Transpl, 2016，22(4)：427-435.
|
| 5 |
Balogh J, Gordon Burroughs S, Boktour M, et al. Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients[J]. Liver Transpl, 2016，22(2)：163-170.
|
| 6 |
Hashemizadeh Z, Badiee P, Malekhoseini SA, et al. Observational study of associations between voriconazole therapeutic drug monitoring, toxicity, and outcome in liver transplant patients[J]. Antimicrob Agents Chemother, 2017，61(12): e01211-e01217.
|
| 7 |
Jin H, Wang T, Falcione BA, et al. Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis[J]. J Antimicrob Chemother 2016，71(7)：1772-1785.
|
| 8 |
Sánchez-Velasco P, Rodrigo E, Valero R, et al. Intracellular ATP concentrations of CD4 cells in kidney transplant patients with and without infection[J]. Clin Transplant, 2008，22(1)：55-60.
|
| 9 |
Iovino L, Taddei R, Bindi ML, et al. Clinical use of an immune monitoring panel in liver transplant recipients: a prospective, observational study[J]. Transpl Immunol, 2019，52：45-52.
|
| 10 |
Ruiz P, Martinez-Picola M, Santana M, et al. Torque teno virus is associated with the state of immune suppression early after liver transplantation[J]. Liver Transpl, 2019，25(2)：302-310.
|
| 11 |
Margeta I, Mareković I, Pešut A, et al. Evaluation of cell-mediated immune response by QuantiFERON Monitor Assay in kidney transplant recipients presenting with infective complications[J]. Medicine (Baltimore), 2020，99(27)：e21010.
|